Dr. Reddy’s Laboratories Ltd. Announces the Launch of Anastrozole 1mg Tablets

June 30, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE:RDY) today announced that it has launched anastrozole tablets, (1mg), a bioequivalent generic version of Arimidex® (anastrozole tablets) in the US market on 28 June 2010.

Twitter
LinkedIn
Facebook
Email
Print

Asia